Antagonistic Cross-Regulation between Sox9 and Sox10 Controls an Anti-tumorigenic Program in Melanoma
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Melanoma is the most fatal skin cancer, but the etiology of this devastating disease is still poorly understood. Recently, the transcription factor Sox10 has been shown to promote both melanoma initiation and progression. Reducing SOX10 expression levels in human melanoma cells and in a genetic melanoma mouse model, efficiently abolishes tumorigenesis by inducing cell cycle exit and apoptosis. Here, we show that this anti-tumorigenic effect functionally involves SOX9, a factor related to SOX10 and upregulated in melanoma cells upon loss of SOX10. Unlike SOX10, SOX9 is not required for normal melanocyte stem cell function, the formation of hyperplastic lesions, and melanoma initiation. To the contrary, SOX9 overexpression results in cell cycle arrest, apoptosis, and a gene expression profile shared by melanoma cells with reduced SOX10 expression. Moreover, SOX9 binds to the SOX10 promoter and induces downregulation of SOX10 expression, revealing a feedback loop reinforcing the SOX10 low/SOX9 high ant,m/ii-tumorigenic program. Finally, SOX9 is required in vitro and in vivo for the anti-tumorigenic effect achieved by reducing SOX10 expression. Thus, SOX10 and SOX9 are functionally antagonistic regulators of melanoma development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“we found amongst our top SALL4-HDAC2 shared de novo DNA binding motifs matches for known transcriptional regulators of the NC that are re-expressed and have functional implication in melanoma, such as SOX10 and SOX948 or RUNX149,50, and also key regulators of melanocyte differentiation and hence melanoma, such as MITF51 or TFAP2C52,53”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [48]
The cited source says what the claim attributes to it.
In the citing paper
“This is reminiscent of melanoma cells displaying reduced SOX10 levels, which is associated with increased expression of SOX9, another factor involved in NC development, and increased invasiveness48,71.”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
Rudin, C. M., Durinck, S., Stawiski, E. W., Poirier, J. T., Modrusan, Z., Shames, D. S., Bergbower, E. A., Guan, Y., Shin, J., Guillory, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2405 · Cited by 1,077
SOX9 directly regulates the type-ll collagen gene
Bell, D. M., Leung, K. K. H., Wheatley, S. C., Ng, L. J., Zhou, S., Wing Ling, K., Har Sham, M., Koopman, P., Tam, P. P. L., & Cheah, K. S. E. (1997) · Nature Genetics · doi:10.1038/ng0697-174 · Cited by 933 · cited 1×
“Moreover, while Sox9 activates the expression of genes involved in the induction of osteochondrogenesis in neural crest cells in pharyngeal arches [26,28,60], Sox10 is involved in the specification of a glial and melanocytic gene expression program [13].”
BackgroundThe Sox Family of Transcription Factors: Versatile Regulators of Stem and Progenitor Cell Fate
Sarkar, A., & Hochedlinger, K. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.007 · Cited by 920 · cited 1×
“Sox genes play key roles in embryonic development and are major determinants of stem cell behavior, regulating cell fate decisions and maintaining cellular identity [3].”
BackgroundThe transcription factor Sox10 is a key regulator of peripheral glial development
Britsch, S., Goerich, D. E., Riethmacher, D., Peirano, R. I., Rossner, M., Nave, K.-A., Birchmeier, C., & Wegner, M. (2001) · Genes & Development · doi:10.1101/gad.186601 · Cited by 914 · cited 2×
“Moreover, while Sox9 activates the expression of genes involved in the induction of osteochondrogenesis in neural crest cells in pharyngeal arches [26,28,60], Sox10 is involved in the specification of a glial and melanocytic gene expression program [13].”
BackgroundSelf-citationDominant role of the niche in melanocyte stem-cell fate determination
Nishimura, E. K., Jordan, S. A., Oshima, H., Yoshida, H., Osawa, M., Moriyama, M., Jackson, I. J., Barrandon, Y., Miyachi, Y., & Nishikawa, S.-I. (2002) · Nature · doi:10.1038/416854a · Cited by 901 · cited 1×
“Melanocyte stem cells are found in a specialized region of the hair follicle called bulge and give rise to melanocyte progenitors and differentiated melanocytes [42].”
BackgroundFrom head to toes: the multiple facets of Sox proteins
Wegner, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.6.1409 · Cited by 890 · cited 1×
“A common feature of SoxE group proteins, which includes Sox9 and Sox10, is their expression in neural crest (NC) cells during embryonic development [2, 11].”
BackgroundSelf-citationSOX10 mutations in patients with Waardenburg-Hirschsprung disease
Pingault, V., Bondurand, N., Kuhlbrodt, K., Goerich, D. E., Préhu, M.-O., Puliti, A., Herbarth, B., Hermans-Borgmeyer, I., Legius, E., Matthijs, G., et al. (1998) · Nature Genetics · doi:10.1038/ng0298-171 · Cited by 825
Self-citationda Silva, S. M., Hacker, A., Harley, V., Goodfellow, P., Swain, A., & Lovell-Badge, R. (1996) · Nature Genetics · doi:10.1038/ng0996-62 · Cited by 795
Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche
Nishimura, E. K., Granter, S. R., & Fisher, D. E. (2005) · Science · doi:10.1126/science.1099593 · Cited by 750 · cited 1×
“When melanocyte stem cells are functionally impaired, they fail to generate melanocytes, which results in hair graying [43].”
Background
Cited by
Items 101–114 of 114
Targeting lncRNAs in human cancer : insights into melanoma and clear cell renal cell carcinoma
Gambi, G. (2021) · theses.fr (ABES) · doi:10.70675/7af0fc37z1d72z4785za771z630db8483a71
Identifying in vivo genetic dependencies of melanocyte and melanoma development
Perlee, S. C., Ma, Y., Hunter, M. V., Swanson, J. B., Cruz, N. M., Ming, Z., Xia, J., Lionnet, T., McGrail, M., & White, R. M. (2025) · eLife · doi:10.7554/elife.100257.3
Identifying in vivo genetic dependencies of melanocyte and melanoma developmentPreprint
Perlee, S. C., Ma, Y., Hunter, M. V., Swanson, J. B., Ming, Z., Xia, J., Lionnet, T., McGrail, M. A., & White, R. M. (2024) · eLife · doi:10.7554/elife.100257.1
Identifying in vivo genetic dependencies of melanocyte and melanoma developmentPreprint
Perlee, S. C., Ma, Y., Hunter, M. V., Swanson, J. B., Cruz, N. M., Ming, Z., Xia, J., Lionnet, T., McGrail, M. A., & White, R. M. (2025) · eLife · doi:10.7554/elife.100257
Characterization of the mechanisms of action of the transcription factor ZEB1 in melanoma
Tang, Y. (2021) · theses.fr (ABES) · doi:10.70675/d147bc89z14e4z4137zadecz307fd2f27136
Identifying in vivo genetic dependencies of melanocyte and melanoma developmentPreprint
Perlee, S. C., Ma, Y., Hunter, M. V., Swanson, J. B., Cruz, N. M., Ming, Z., Xia, J., Lionnet, T., McGrail, M. A., & White, R. M. (2025) · eLife · doi:10.7554/elife.100257.2
On the origin of melanoma targeted therapy resistance
Raaijmakers, M. I. G. (2017) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-204950
Li, Z. (2023) · Nottingham ePrints (University of Nottingham)
Exploring the Link Between PACAP Signalling and Hyaluronic Acid Production in Melanoma Progression
Hajdú, T., Kovács, P., Katona, É., Nguyen, M. N., Vágó, J., Fillér, C., Zákány, R., Emri, G., Tóth, G., Reglődi, D., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412049
“Another target of PKA could be SOX9 in melanoma cells as it is involved in promoting a cancer stem cell phenotype, contributing to tumour heterogeneity with the crosstalk of SOX10 [44].”
Abou‐Hamad, J., Delisle, S., Garland, B., Hersi, M., Cook, D. P., & Sabourin, L. A. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120118
Role of SoxE transcription factors in development and disease
Lawrence, M., & Schlosser, G. (2026) · Developmental Dynamics · doi:10.1002/dvdy.70130
Epigenetic regulation of gene expression during melanocyte and melanoma development
Laurette, P. (2016) · theses.fr (ABES) · doi:10.70675/b22b69c4z85a0z409czaccczc882ea46e923
Importance de l'axe AhR/Src dans la reprogrammation des mélanomes métastasiques
Paris, A. (2021) · theses.fr (ABES) · doi:10.70675/aa73ebffz8914z40bazb170z7d5c3e02bc0f
Metadata
- Authors
- Shakhova, O., Cheng, P., Mishra, P. J., Zingg, D., Schaefer, S. M., Debbache, J., Häusel, J., Matter, C., Guo, T., Davis, S., Meltzer, P., Mihic-Probst, D., Moch, H., Wegner, M., Merlino, G., Levesque, M. P., Dummer, R., Santoro, R., Cinelli, P., & Sommer, L.
- Affiliations
- University of Zurich (CH)
- University Hospital Zurich (CH)
- National Institutes of Health (US)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Corresponding author
- Sommer, Lukas
- ORCID
- Venue
- PLOS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-01-28
- Volume
- 11
- Issue
- 1
- Pages
- e1004877
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC4309598
- OpenAlex
- W2052814985
- Cited by
- 111
- References
- 63
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 7 · 2023: 9 · 2022: 13 · 2021: 9 · 2020: 11 · 2019: 12 · 2018: 7 · 2017: 11 · 2016: 15 · 2015: 3
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS Genetics (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, public-domain)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, public-domain)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Universität Zürich
- Promedica Stiftung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Keywords
- melanoma, SOX9, SOX10, transcription factor antagonism, cross-regulation, cell cycle arrest, apoptosis, melanocyte stem cells, feedback loops, tumor suppression
- MeSH terms
- Animals, Humans, Melanocytes, Melanoma, Gene Expression Regulation, Neoplastic, Apoptosis, Hair Follicle, RNA, Small Interfering, Cell Line, Tumor, Mice, SOXE Transcription Factors, SOX9 Transcription Factor, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.